A comparison of carvedilol and metoprolol antioxidant activities in vitro

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 2, 2000, Pages 277-281

  Lysko, Paul G ^a   Webb, Christine L ^a   Gu, Juan Li ^a   Ohlstein, Eliot H ^a   Ruffolo Jr , Robert R ^a   Yue, Tian Li ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antioxidant; Cerebellar neuron; Free radical; Thiobarbituric acid reactive substance

Indexed keywords

CARVEDILOL; FREE RADICAL; LIPID; METOPROLOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; HEART; HEART PROTECTION; IN VITRO STUDY; LIPID PEROXIDATION; LIPOPHILICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

EID: 0033847635     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200008000-00001     Document Type: Article

References (25)

1. Myocardial protection with carvedilol
2. Carvedilol, a new vasodilator and β-adrenoceptor antagonist, inhibits oxygen-radical-mediated lipid peroxidation in swine ventricular membranes
3. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger
4. Carvedilol, a new vasodilating β adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils
5. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model
6. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury
7. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients
8. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol
9. Beta-blockade in heart failure: A comparison of carvedilol with metoprolol
10. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
11. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids
12. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia
13. Neuroprotective activities of carvedilol and a hydroxylated derivative: Role of membrane biophysical interactions
14. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation
15. Protection by β-blocking agents against free radical-mediated sarcolemmal lipid peroxidation
16. Differential effect of cholesterol on membrane interaction of charged versus uncharged 1,4-dihydropyridine calcium channel antagonists: A biophysical analysis
17. Carvedilol-liposome interaction: Evidence for strong association with the hydrophobic region of the lipid bilayers
18. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant
19. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts
20. Effect of beta-blockers on free radical-induced cardiac contractile dysfunction
21. Pharmacokinetics and disposition of carvedilol in humans
22. Modulation of the physical state of cellular cholesteryl esters by 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (Probucol)
23. Functional and structural aspects of biological membranes: A suggested role for vitamin E in the control of membrane permeability and stability
24. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients
25. Carvedilol: A novel multiple action anti-hypertensive drug